The zygomycetes are saprophytic fungi that rarely cause disease in the norm
al human host. In immunocompromised individuals, these organisms can cause
invasive infections, collectively called mucormycosis. Mucormycosis is asso
ciated with a high mortality rate, especially in organ transplant recipient
s. In this report, we describe the first case of successfully treated mucor
mycosis involving a pulmonary allograft. Treatment consisted of surgical ex
cision of the affected lobe and chest wall and lipid-complex amphotericin B
. The lipid complex formulation permitted a prolonged course of therapy tha
t was likely critical to eradication of the infection.